Extravascular solutions allow physicians to deliver critical therapy while maintaining the integrity of the heart, commented ...

AtaCor Medical launched its clinical study evaluating its extravascular implantable cardioverter defibrillator (EV-ICD) lead ...

Alexion, AstraZeneca Rare Disease has received the US Food and Drug Administration's (FDA) approval for Voydeya (danicopan) as an add-on therapy to treat extravascular haemolysis (EVH) in adults ...

Omeros (OMER) reported that clinical trial site activation for enrollment is underway for the company’s Phase 3 program evaluating zaltenibart ...